Skip to main content

Market Overview

40 Stocks Moving In Tuesday's Mid-Day Session



  • Audentes Therapeutics Inc (NASDAQ: BOLD) shares jumped 105.9% to $58.90 after the company agreed to be acquired by Astellas Pharma for $60 per share in cash.
  • DarioHealth Corp. (NASDAQ: DRIO) gained 57.9% to $7.91 after the company reported the launch of Dario-powered digital diabetes program on
  • ViewRay, Inc. (NASDAQ: VRAY) shares rose 31.8% to $4.48 after the company announced it has signed a memorandum of understanding for collaboration with Elekta AB and Medtronic. The company also announced a $75 million common stock offering.
  • Calyxt, Inc. (NASDAQ: CLXT) gained 25% to $4.5563.
  • Akerna Corp. (NASDAQ: KERN) surged 17.7% to $10.66.
  • uniQure N.V. (NASDAQ: QURE) rose 15.1% to $63.03 after analysts from Goldman Sachs and Cowen & Co initiated coverage on the company's stock with bullish ratings.
  • Lands' End, Inc. (NASDAQ: LE) shares gained 13.9% to $13.40 after reporting upbeat Q3 earnings.
  • Axsome Therapeutics, Inc. (NASDAQ: AXSM) shares rose 13.4% to $44.94 after the company disclosed that AXS-12 achieved primary endpoint in concert Phase 2 trial in narcolepsy.
  • REGENXBIO Inc. (NASDAQ: RGNX) jumped 11.4% to $45.32.
  • Kodiak Sciences Inc. (NASDAQ: KOD) gained 9.5% to $55.89. In Monday’s regular session, the company announced the sale of future royalties on KSI-301 to Baker Bros. Advisors for $225 million. Shares spiked roughly 70% during regular trading. In Tuesday’s after-hours session, the company announced a $250 million common stock offering.
  • Harmony Gold Mining Company Limited (NYSE: HMY) rose 9% to $3.225 amid US-China trade uncertainty after Trump implied a deal many not be reached until 2020. Continuing trade war concerns have led investors into 'safe-haven' assets such as gold and silver.
  • Sibanye Gold Limited (NYSE: SBGL) rose 8.2% to $8.74.
  • Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) gained 8% to $68.45. Arrowhead Pharmaceuticals said it intends to offer 4 million shares of its common stock in an underwritten public offering.
  • Sangamo Therapeutics, Inc. (NASDAQ: SGMO) climbed 8.1% to $11.56 in sympathy with Audentes Therapeutics after the company announced it will be acquired by Astellas Pharma for $60 per share in cash.
  • Sorrento Therapeutics, Inc. (NASDAQ: SRNE) shares rose 7% to $3.65.
  • Amneal Pharmaceuticals Inc (NYSE: AMRX) gained 6% to $4.07 after the company reported the FDA approval and launch of generic carafate.
  • AK Steel Holding Corporation (NYSE: AKS) rose 3.6% to $2.99 after Cleveland-Cliffs announced plans to acquire the company for $3.36 per share.

Check out these big penny stock gainers and losers


  • ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) shares dipped 46.7% to $2.77 after the company priced a 5.2 million ADS offering at $2.50 per ADS.
  • CBL & Associates Properties, Inc. (NYSE: CBL) fell 30.3% to $0.9414 after announcing the suspension of common and preferred stock dividends. The company says it sees a decline in net operating income as a result of ‘heightened retailer bankruptcies, restructurings and store closings in 2019.’
  • Cara Therapeutics, Inc. (NASDAQ: CARA) dropped 27.6% to $18.73 after the company reported mixed results from its Phase 2 trial of Oral Korsuva in chronic kidney disease patients with moderate-to-severe pruritus.
  • Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) dipped 26.8% to $5.48 after the company announced positive top-line results from Part 1 of the adaptive Phase 3 study dubbed RENEW, which evaluated ADX-102 (topical ocular reproxalap) for dry eye syndrome. ADX-102 was found statistically superior to vehicle in Ocular Discomfort &4-Symptom Questionnaire ocular endpoints for dryness, discomfort, burning, grittiness and stinging. For the co-primary endpoint of fluorescein nasal region ocular staining, it did not reach statistical significance.
  • Protagonist Therapeutics, Inc. (NASDAQ: PTGX) dropped 26.6% to $6.50 after the company reported preliminary Phase 2 results with hepcidin mimetic PTG-300 in the treatment of transfusion dependent beta-thalassemia.
  • Eyenovia, Inc. (NASDAQ: EYEN) fell 15.2% to $3.41.
  • Liquid Media Group Ltd. (NASDAQ: YVR) dipped 13.8% to $2.9652.
  • Cleveland-Cliffs Inc. (NYSE: CLF) fell 13.6% to $7.26 after the company announced it will acquire AK Steel for approximately $3 billion.
  • Duluth Holdings Inc. (NASDAQ: DLTH) dropped 11.5% to $8.01. Stifel Nicolaus maintained Duluth Holdings with a Hold and lowered the price target from $11 to $9.
  • Akari Therapeutics, Plc (NASDAQ: AKTX) shares declined 11.1% to $1.92.
  • Plug Power Inc. (NASDAQ: PLUG) fell 10.4% to $3.4039 after the company announced a 40 million share common stock offering.
  • NF Energy Saving Corporation (NASDAQ: BIMI) shares tumbled 10% to $3.0527.
  • Tufin Software Technologies Ltd. (NYSE: TUFN) dropped 9.1% to $17.35 after the company announced the launch of secondary public offering of ordinary shares.
  • Clovis Oncology, Inc. (NASDAQ: CLVS) shares dipped 9.1% to $14.93.
  • Venator Materials PLC (NYSE: VNTR) dropped 8.8% to $3.53.
  • Safe-T Group Ltd (NASDAQ: SFET) dipped 8.7% to $5.60.
  • Adient plc (NYSE: ADNT) fell 8.7% to $20.54.
  • TTEC Holdings Inc (NASDAQ: TTEC) fell 8.1% to $41.11 after the company reported a 3 million share offering by selling shareholders.
  • RPC, Inc. (NYSE: RES) fell 8% to $3.575.
  • Avita Medical Limited (NASDAQ: RCEL) shares dropped 7.8% to $7.79.
  • Coupa Software Inc (NASDAQ: COUP) shares fell 6.4% to $139.40 after the company reported Q3 earnings results.
  • Livongo Health, Inc. (NASDAQ: LVGO) dipped 6% to $26.01 with the overall market on global macro concerns after Trump implied a US-China trade deal may not occur until 2020.
  • DouYu International Holdings Ltd (NASDAQ: DOYU) dropped 5.1% to $7.13 after JP Morgan downgraded the company's stock from Overweight to Neutral and lowered the price target from $10 to $8.

Related Articles (AKS + ADNT)

View Comments and Join the Discussion!

Posted-In: Mid-Day GainersNews Movers & Shakers Intraday Update Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at